veristat Infographics
- 
                    Accelerating Patient-Centric Trials With A Sponsor's Checklist
                        8/12/2025
                    Effective trial success in today’s complex research environment requires early planning. This checklist will help you to strengthen planning, elevate patient engagement, and drive submission success. 
- 
                    How Does RWE Impact Clinical Trials?
                        4/10/2025
                    Explore the growing impact of Real-World Evidence (RWE) on clinical trials, particularly in rare disease research. 
- 
                    FDA Guidance On The Use Of DMCs In Clinical Trials
                        9/4/2024
                    Gain an overview of FDA guidance on the use of Data Monitoring Committees (DMCs) in clinical trials and their critical role in safeguarding patient safety and ensuring unbiased decision-making. 
- 
                    Understanding Data Monitoring Committees
                        9/4/2024
                    Data Monitoring Committees (DMCs) provide independent oversight in clinical trials. Discover how expertise in organizing DMCs strengthens trial integrity through rigorous risk-benefit assessments. 
- 
                    Successfully Prepare Structure-Data Files For Regulatory Submissions
                        8/31/2023
                    Review the guidelines for creating an SD file and the updated process for submitting to the FDA's KASA review program to best prepare regulatory submissions. 
- 
                    FDA Meeting Types With CDER And CBER For Biosimilar Products
                        6/7/2023
                    Get a summary of the different types of meetings under BsUFA for biosimilar products, including their applicability, examples, and the timing parameters of each meeting type. 
- 
                    Enhancing Trial Efficiency With Thoughtful Database Design
                        2/17/2023
                    Better understand the key considerations that should be discussed prior to designing a clinical trial database, all of which can impact the efficiency of the clinical program. 
- 
                    Autologous Vs. Allogeneic Cell And Gene Therapies
                        1/17/2023
                    There are two types of cell therapies in development: autologous and allogeneic. Each provides distinct clinical and production advantages and challenges, and therapeutic capabilities. 
- 
                    Shortening Development And Approval Timelines For Medicinal Products
                        12/7/2022
                    Discover a strategic regulatory plan and leverage the right pathways to drive faster and more efficient drug development. 
- 
                    Lessons Learned For Better Planning Of Decentralized Clinical Trials
                        9/9/2022
                    Planning a decentralized clinical trial brings with it new challenges to overcome. Learn how to navigate this novel approach designed with a custom virtual ecosystem to satisfy both study and patient needs. 
